Tumor suppression by collagen XV is independent of the restin domain

Matrix Biology

Volumn 31, Issue 5, 2012, Pages 285-289

  Mutolo, Michael J ^a   Morris, Kirsten J ^a   Leir, Shih Hsing ^a   Caffrey, Thomas C ^a   Lewandowska, Marzena A ^a   Hollingsworth, Michael A ^b   Harris, Ann ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Adhesion; Collagen XV; Restin domain; Tumor suppression

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 15; COLLAGEN TYPE 18; CYSTEINE; ENDOSTATIN; RESTIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL ADHESION; MOLECULAR INTERACTION; MOUSE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; UTERINE CERVIX CARCINOMA;

ANIMALS; ANTINEOPLASTIC AGENTS; BASEMENT MEMBRANE; CELL ADHESION; CERCOPITHECUS AETHIOPS; COLLAGEN; COLLAGEN TYPE I; COS CELLS; CYSTEINE; EXTRACELLULAR MATRIX; FEMALE; GENETIC VECTORS; KAPLAN-MEIER ESTIMATE; MICE; MICE, NUDE; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; TRANSFECTION; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84861695561     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2012.03.003     Document Type: Article

References (25)

1. Amenta P.S., Briggs K., Xu K., Gamboa E., Jukkola A.F., Li D., Myers J.C. Type XV collagen in human colonic adenocarcinomas has a different distribution than other basement membrane zone proteins. Hum. Pathol. 2000, 31:359-366.
2. Amenta P.S., Hadad S., Lee M.T., Barnard N., Li D., Myers J.C. Loss of types XV and XIX collagen precedes basement membrane invasion in ductal carcinoma of the female breast. J. Pathol. 2003, 199:298-308.
3. Amenta P.S., Scivoletti N.A., Newman M.D., Sciancalepore J.P., Li D., Myers J.C. Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the basement membrane. J. Histochem. Cytochem. 2005, 53:165-176.
4. Brideau G., Makinen M.J., Elamaa H., Tu H., Nilsson G., Alitalo K., Pihlajaniemi T., Heljasvaara R. Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice. Cancer Res. 2007, 67:11528-11535.
5. Cooke V.G., Kalluri R. Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis. Methods Enzymol. 2008, 444:1-19.
6. Evans E.P., Burtenshaw M.D., Brown B.B., Hennion R., Harris H. The analysis of malignancy by cell fusion. IX. Re-examination and clarification of the cytogenetic problem. J. Cell Sci. 1982, 56:113-130.
7. Fukushige T., Kanekura T., Ohuchi E., Shinya T., Kanzaki T. Immunohistochemical studies comparing the localization of type XV collagen in normal human skin and skin tumors with that of type IV collagen. J. Dermatol. 2005, 32:74-83.
8. Gaetzner S., Deckers M.M., Stahl S., Lowik C., Olsen B.R., Felbor U. Endostatin's heparan sulfate-binding site is essential for inhibition of angiogenesis and enhances in situ binding to capillary-like structures in bone explants. Matrix Biol. 2005, 23:557-561.
9. Hagg P.M., Muona A., Lietard J., Kivirikko S., Pihlajaniemi T. Complete exon-intron organization of the human gene for the alpha1 chain of type XV collagen (COL15A1) and comparison with the homologous COL18A1 gene. J. Biol. Chem. 1998, 273:17824-17831.
10. Harris H. Suppression of malignancy in hybrid cells: the mechanism. J. Cell Sci. 1985, 79:83-94.
11. Harris H. Is collagen XV a tumor suppressor?. DNA Cell Biol. 2003, 22:225-226.
12. Harris H. A long view of fashions in cancer research. Bioessays 2005, 27:833-838.
13. Harris H., Bramwell M.E. The suppression of malignancy by terminal differentiation: evidence from hybrids between tumour cells and keratinocytes. J. Cell Sci. 1987, 87(Pt 3):383-388.
14. Harris A., Harris H., Hollingsworth M.A. Complete suppression of tumor formation by high levels of basement membrane collagen. Mol. Cancer Res. 2007, 5:1241-1245.
15. Hurskainen M., Ruggiero F., Hagg P., Pihlajaniemi T., Huhtala P. Recombinant human collagen XV regulates cell adhesion and migration. J. Biol. Chem. 2010, 285:5258-5265.
16. John H., Radtke K., Standker L., Forssmann W.G. Identification and characterization of novel endogenous proteolytic forms of the human angiogenesis inhibitors restin and endostatin. Biochim. Biophys. Acta 2005, 1747:161-170.
17. Jonasson J., Povey S., Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J. Cell Sci. 1977, 24:217-254.
18. Leir S.H., Holgate S.T., Lackie P.M. Inflammatory cytokines can enhance CD44-mediated airway epithelial cell adhesion independently of CD44 expression. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1305-L1311.
19. Li D., Clark C.C., Myers J.C. Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 2000, 275:22339-22347.
20. Myers J.C., Kivirikko S., Gordon M.K., Dion A.S., Pihlajaniemi T. Identification of a previously unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-helical region. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:10144-10148.
21. Myers J.C., Dion A.S., Abraham V., Amenta P.S. Type XV collagen exhibits a widespread distribution in human tissues but a distinct localization in basement membrane zones. Cell Tissue Res. 1996, 286:493-505.
22. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88:277-285.
23. Ramchandran R., Dhanabal M., Volk R., Waterman M.J., Segal M., Lu H., Knebelmann B., Sukhatme V.P. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem. Biophys. Res. Commun. 1999, 255:735-739.
24. Sasaki T., Larsson H., Tisi D., Claesson-Welsh L., Hohenester E., Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 2000, 301:1179-1190.
25. Wirz J.A., Boudko S.P., Lerch T.F., Chapman M.S., Bachinger H.P. Crystal structure of the human collagen XV trimerization domain: a potent trimerizing unit common to multiplexin collagens. Matrix Biol. 2011, 30:9-15.